Core Viewpoint - The company, Yidu Tech (02158), is actively repurchasing shares, signaling confidence in its long-term value while also making significant strides in business collaborations within the healthcare sector [1] Group 1: Share Repurchase - On January 30, Yidu Tech repurchased approximately 786,000 shares at around HKD 5.8 per share, costing over HKD 4.5 million [1] - The total amount spent on share repurchases over the past five days exceeds HKD 9.5 million, indicating a strong commitment to enhancing shareholder value [1] Group 2: Business Collaborations - Yidu Tech has established a strategic partnership with the Nanshan District People's Hospital in Shenzhen, launching the first domestic "AI + Health Management" innovative system that covers "full-time, full-domain, full-population, and full-cycle" [1] - This initiative aims to create a closed-loop AI medical ecosystem from research and development to application and transformation, marking a significant step in the implementation of smart healthcare solutions [1] Group 3: Market Developments - The company has reported that the number of participants in the 2026 "Beijing Universal Health Insurance" program has surpassed 4.5 million, showcasing its operational capabilities [1] - Additionally, Yidu Tech has collaborated with the First Affiliated Hospital of Chongqing Medical University to launch an "AI Assistant for General Medicine," further expanding its influence in the healthcare sector [1] - Market observers note that the combination of continuous share repurchases and multiple business collaborations highlights the company's dual strategy of "technological breakthroughs + scenario implementation," deepening its impact in the fields of medical intelligence and universal health [1]
医渡科技周内5次回购超950万港元 携手南山医院推出国内首个“AI+健康管理”创新体系